Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 48Recruiting 33Completed 30Not yet recruiting 24Active not recruiting 13Terminated 12Withdrawn 3Suspended 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 17Neoplasms 7Colorectal Neoplasms 6Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Mesothelioma 4Prostatic Neoplasms 3Ovarian Neoplasms 3Mesothelioma, Malignant 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2NSCLC 2Melanoma 2Endometrial Neoplasms 2Diabetes Mellitus 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Psoriasis 1Post-Lyme Disease Syndrome 1Pneumonia 1Parkinson Disease 1Pancreatic Neoplasms 1Osteosarcoma 1Obsessive-Compulsive Disorder 1Neoplasms, Squamous Cell 1

Interventions

HM781-36B 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × NSCLC × Thoracic × Clear all
NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended
268 enrolled
Thoracic

NSCLC

NCT00280189 2026-04-14

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

University of Pittsburgh

Suspended
72 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡